Breaking Dermatology Literature: A Probiotic for AD, A JAK Inhibitor for Pemphigoid & IL-23 Inhibitors for Guttate Psoriasis

Get ahead of the curve with Derms on Drugs as we break down the most exciting new dermatology research! This week features game-changing studies including an oral probiotic with stunning results for atopic dermatitis, JAK inhibitors for bullous pemphigoid, and IL-23 inhibitors tackling guttate psoriasis.

Plus, we dive deep into:

• Dermoscopy advances for managing longitudinal melanonychia

• If failing an IL-13 inhibitor affects the chances of doing well on another IL-13 inhibitor

• New data on IL-13 inhibitor induced conjunctivitis

• Red light PDT efficacy for superficial basal cell carcinoma

• Early systemic PDE4 inhibition strategies in psoriasis

• Follicular event insights from tapinarof studies

• PDE4 inhibition potential for vitiligo treatment

Perfect for dermatology providers who want cutting-edge clinical pearls they can apply immediately. Tune in for evidence-based insights, practical takeaways, and the signature Derms on Drugs commentary that keeps you engaged while staying current.

See more at ScholarsInMedicine.com